Jordi Tor

1.8k total citations
75 papers, 1.2k citations indexed

About

Jordi Tor is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jordi Tor has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 26 papers in Hepatology and 21 papers in Infectious Diseases. Recurrent topics in Jordi Tor's work include Hepatitis C virus research (25 papers), Liver Disease Diagnosis and Treatment (23 papers) and Alcohol Consumption and Health Effects (19 papers). Jordi Tor is often cited by papers focused on Hepatitis C virus research (25 papers), Liver Disease Diagnosis and Treatment (23 papers) and Alcohol Consumption and Health Effects (19 papers). Jordi Tor collaborates with scholars based in Spain, United States and Germany. Jordi Tor's co-authors include Roberto Muga, Arantza Sanvisens, Daniel Fuster, Celestino Rey‐Joly, Bonaventura Clotet, Ferrán Bolao, Cristina Tural, Ramón Planas, Guillem Sirera and Pere Tudela and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Jordi Tor

73 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Tor Spain 21 750 414 364 170 143 75 1.2k
Janet Tate United States 16 406 0.5× 116 0.3× 354 1.0× 76 0.4× 121 0.8× 30 994
Mark Johnson United States 22 859 1.1× 238 0.6× 295 0.8× 30 0.2× 131 0.9× 53 1.8k
Tamsin A. Knox United States 25 648 0.9× 289 0.7× 752 2.1× 64 0.4× 308 2.2× 53 2.3k
Chiara Stentarelli Italy 18 358 0.5× 150 0.4× 353 1.0× 28 0.2× 196 1.4× 34 977
Sergio Reus Spain 14 291 0.4× 69 0.2× 253 0.7× 33 0.2× 124 0.9× 64 633
S. Herrmann Australia 16 259 0.3× 151 0.4× 436 1.2× 14 0.1× 308 2.2× 40 997
Sean G. Kelly United States 18 246 0.3× 152 0.4× 307 0.8× 10 0.1× 169 1.2× 59 740
Rachel Baden United States 12 412 0.5× 161 0.4× 815 2.2× 12 0.1× 34 0.2× 22 1.3k
Kathleen Melbourne United States 13 180 0.2× 57 0.1× 898 2.5× 132 0.8× 543 3.8× 28 1.5k
Silvia Guillemi Canada 24 998 1.3× 68 0.2× 1.1k 3.1× 17 0.1× 405 2.8× 74 1.7k

Countries citing papers authored by Jordi Tor

Since Specialization
Citations

This map shows the geographic impact of Jordi Tor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Tor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Tor more than expected).

Fields of papers citing papers by Jordi Tor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Tor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Tor. The network helps show where Jordi Tor may publish in the future.

Co-authorship network of co-authors of Jordi Tor

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Tor. A scholar is included among the top collaborators of Jordi Tor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Tor. Jordi Tor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuster, Daniel, et al.. (2020). Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence. 216. 108231–108231. 1 indexed citations
2.
Bolao, Ferrán, et al.. (2019). Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL‐6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcoholism Clinical and Experimental Research. 44(1). 152–158. 10 indexed citations
3.
Muga, Roberto, Arantza Sanvisens, Inmaculada Jarrín, et al.. (2018). Hepatitis C infection substantially reduces survival of alcohol-dependent patients. Clinical Epidemiology. Volume 10. 897–905. 8 indexed citations
4.
Fuster, Daniel, et al.. (2018). Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug and Alcohol Dependence. 190. 195–199. 7 indexed citations
5.
Sanvisens, Arantza, Álvaro Muñoz, Ferrán Bolao, et al.. (2018). Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?. Drug and Alcohol Dependence. 188. 180–186. 5 indexed citations
6.
Sanvisens, Arantza, Daniel Fuster, Ferrán Bolao, et al.. (2017). Folate deficiency in patients seeking treatment of alcohol use disorder. Drug and Alcohol Dependence. 180. 417–422. 18 indexed citations
7.
Sanvisens, Arantza, et al.. (2016). Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium. International Journal of Molecular Sciences. 17(3). 417–417. 7 indexed citations
8.
Sanvisens, Arantza, Aina Teniente‐Serra, Daniel Fuster, et al.. (2016). Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. Drug and Alcohol Dependence. 162. 124–129. 8 indexed citations
9.
Sanvisens, Arantza, Gabriel Vallecillo, Ferrán Bolao, et al.. (2014). Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain. Drug and Alcohol Dependence. 136. 115–120. 5 indexed citations
10.
Tor, Jordi, Roberto Muga, Antoni Jou, et al.. (2012). Effect of Liver Fibrosis on Long-Term Mortality in HIV/Hepatitis C Virus-Coinfected Individuals Who Are Evaluated to Receive Interferon Therapies in the Highly Active Antiretroviral Therapy Era. AIDS Research and Human Retroviruses. 28(10). 1235–1243. 6 indexed citations
11.
Tudela, Pere, et al.. (2012). Biomarcadores para la predicción en urgencias de infección bacteriana, bacteriemia y gravedad. Emergencias: Revista de la Sociedad Española de Medicina de Urgencias y Emergencias. 24(5). 348–356. 17 indexed citations
12.
Muga, Roberto, Arantza Sanvisens, Daniel Fuster, et al.. (2012). Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C. PLoS ONE. 7(10). e46810–e46810. 23 indexed citations
13.
Fuster, Daniel, Jordi Tor, Celestino Rey‐Joly, & Roberto Muga. (2011). Interacciones patogénicas entre alcohol y hepatitis C. Medicina Clínica. 138(14). 627–632. 6 indexed citations
14.
Sanvisens, Arantza, Daniel Fuster, Jordi Tor, et al.. (2011). Estimated Liver Fibrosis and its Impact on All-Cause Mortality of HCV-Monoinfected and HCV/HIV-Coinfected Drug Users. Current HIV Research. 9(4). 256–262. 16 indexed citations
15.
Muga, Roberto, Arantza Sanvisens, Ferrán Bolao, et al.. (2006). Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987–2001. Drug and Alcohol Dependence. 82. S29–S33. 38 indexed citations
16.
Fuster, Daniel, Ramón Planas, Roberto Muga, et al.. (2004). Advanced Liver Fibrosis in HIV/HCV-Coinfected Patients on Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(12). 1293–1297. 44 indexed citations
17.
Tural, Cristina, Daniel Fuster, Jordi Tor, et al.. (2003). Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients. Journal of Viral Hepatitis. 10(2). 118–125. 81 indexed citations
18.
Bechini, Jordi, et al.. (2001). Evaluación de la interpretación de la radiografía de tórax por los médicos de guardia en un hospital universitario. Medicina Clínica. 117(9). 332–333. 7 indexed citations
19.
Schmit, Jean‐Claude, Lı́dia Ruiz, Bonaventura Clotet, et al.. (1996). Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS. 10(9). 995–999. 92 indexed citations
20.
Rubio-Terrés, Carlos, et al.. (1995). Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. European Respiratory Journal. 8(11). 1929–1933. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet Tate Breakdown of academic impact, for papers by Mark Johnson Breakdown of academic impact, for papers by Tamsin A. Knox Breakdown of academic impact, for papers by Chiara Stentarelli Breakdown of academic impact, for papers by Sergio Reus Breakdown of academic impact, for papers by S. Herrmann Breakdown of academic impact, for papers by Sean G. Kelly Breakdown of academic impact, for papers by Rachel Baden Breakdown of academic impact, for papers by Kathleen Melbourne Breakdown of academic impact, for papers by Silvia Guillemi
Rankless by CCL
2026